Literature DB >> 7087042

BCG induced murine peritoneal exudate cells: cytotoxic activity against a syngeneic bladder tumor cell line.

A S Pang, A Morales.   

Abstract

Peritoneal exudate cells from mice after intraperitoneal injection of 10 mg. of BCG demonstrated cytolytic activity in vitro against the syngeneic bladder tumor cell line MBT-2. The cytolytic effector cells are nonadherent, nonphagocytic and trypsin resistant. Moreover these cells are cyclophosphamide and hydrocortisone sensitive. It is suggested that an NK-like cell constitutes the major, if not all the population of effector cells in this reaction.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7087042     DOI： 10.1016/s0022-5347(17)54303-7

Source DB:  PubMed          Journal:  J Urol        ISSN： 0022-5347            Impact factor:   7.450


  10 in total

1.  Systemic immune response after intravesical instillation of bacille Calmette-Guérin (BCG) for superficial bladder cancer.

Authors:  K Taniguchi; S Koga; M Nishikido; S Yamashita; T Sakuragi; H Kanetake; Y Saito
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

2.  Fibronectin-mediated Calmette-Guerin bacillus attachment to murine bladder mucosa. Requirement for the expression of an antitumor response.

Authors:  L R Kavoussi; E J Brown; J K Ritchey; T L Ratliff
Journal:  J Clin Invest       Date:  1990-01       Impact factor: 14.808

3.  Interleukin-10 inhibits Mycobacterium bovis bacillus Calmette-Guérin (BCG)-induced macrophage cytotoxicity against bladder cancer cells.

Authors:  Y Luo; R Han; D P Evanoff; X Chen
Journal:  Clin Exp Immunol       Date:  2010-02-10       Impact factor: 4.330

4.  Anti-tumor effect of intravesical instillation of OK432 against rat bladder tumors induced by N-butyl-N-(4-hydroxybutyl) nitrosamine.

Authors:  H Tsujihashi; H Matsuda; S Uejima; T Akiyama; T Kurita
Journal:  Urol Res       Date:  1990

5.  BCG induced killer cell activity.

Authors:  S Koga; T Kiyohara; K Taniguchi; M Nishikido; S Kubota; T Sakuragi; K Shindo; Y Saitoh
Journal:  Urol Res       Date:  1988

6.  Induction of controlled prostatic tissue necrosis by bacille Calmette-Guérin derivatives.

Authors:  A Morales; J C Nickel; P N Manley
Journal:  Urol Res       Date:  1991

7.  Recombinant Mycobacterium bovis bacillus Calmette-Guérin (BCG) expressing mouse IL-18 augments Th1 immunity and macrophage cytotoxicity.

Authors:  Y Luo; H Yamada; X Chen; A A Ryan; D P Evanoff; J A Triccas; M A O'Donnell
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

8.  Induction of tumour necrosis factor-alpha (TNF-alpha) mRNA in bladders and spleens of mice after intravesical administration of bacillus Calmette-Guérin.

Authors:  J S Shin; J H Park; J D Kim; J M Lee; S J Kim
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

9.  Experimental immunotherapy with NK-like cells. A preliminary report.

Authors:  A Morales; A S Pang
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

Review 10.  Neutrophils and TRAIL: insights into BCG immunotherapy for bladder cancer.

Authors:  Mark P Simons; William M Nauseef; Thomas S Griffith
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.